Peter Kuhnert

Title: Peter Kuhnert: Innovator in TNF Receptor Research

Introduction

Peter Kuhnert is a notable inventor based in Berne, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor (TNF) receptors. With a total of 2 patents to his name, Kuhnert's work has implications for understanding and treating various diseases.

Latest Patents

Kuhnert's latest patents focus on the p75 TNF receptor promoters. One of his key inventions is a DNA molecule that contains the endogenous first intron-located p55 TNF-R gene promoter/enhancer sequence. Additionally, he has developed a DNA molecule that includes a gene in operative association with a promoter sequence that features the endogenous first intron-located p55 TNF-R gene promoter/enhancer sequence. These innovations are crucial for advancing research in TNF receptor biology.

Career Highlights

Throughout his career, Kuhnert has been associated with Yeda Research and Development Co. Ltd. His work has been instrumental in pushing the boundaries of genetic research and therapeutic applications. His expertise in the field has garnered attention and respect from peers and industry professionals alike.

Collaborations

Kuhnert has collaborated with esteemed colleagues, including David Wallach and Oliver Kemper. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of TNF receptors.

Conclusion

Peter Kuhnert stands out as an influential inventor in the realm of biotechnology, particularly for his work on TNF receptors. His patents and collaborations reflect his commitment to advancing scientific understanding and innovation.